LINDSEY MOECKEL: Open Payments
NPI 1700456589 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 22 payments from 8 companies in 2025. Trend: 2023 $356 · 2024 $461 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $197 |
| GENZYME CORPORATION | 4 | $97 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| Inspire Medical Systems, Inc. | 3 | $67 |
| Smith+Nephew, Inc. | 1 | $50 |
| Integra LifeSciences Corporation | 1 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: NUCALA, DUPIXENT, INSPIRE, HALO, ACCLARENT AERA.
Industry payments across KS — which companies pay providers there.
